Mark V. Sherrid

Also affiliated with Hinge Health, Diabetes & Endocrine Associates, New York University

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Analysis of three-chamber view conventional and tagged cine MRI in patients with suspected hypertrophic cardiomyopathy”.

Analysis of three-chamber view conventional and tagged cine MRI in patients with suspected hypertrophic cardiomyopathy

Magnetic Resonance Materials in Physics Biology and Medicine(2020)10.1007/s10334-020-00836-6

N/A

0DataRank · unranked

0 citations

Mikael Kanski, Lennart Tautz, Anja Hennemuth, Dan G. Halpern, Mark V. Sherrid +2 more

Common genetic variants and modifiable risk factors underpin hypertrophic cardiomyopathy susceptibility and expressivity

Nature Genetics(2021)10.1038/s41588-020-00764-0

N/A

0DataRank · unranked

344 citations

Anuj Goel, Christopher Grace, Kate Thomson, Steffen E. Petersen, Xiao Hua Xu +64 more

Histopathology of the Mitral Valve Residual Leaflet in Obstructive Hypertrophic Cardiomyopathy

JACC Advances(2023)10.1016/j.jacadv.2023.100308

N/A

0DataRank · unranked

16 citations

Navneet Narula, Daniele Massera, Elizabeth Adlestein, Isabel Castro Alvarez, Paul M.L. Janssen +9 more

Comprehensive Proteomic Profiling of Human Myocardium Reveals Signaling Pathways Dysregulated in Hypertrophic Cardiomyopathy

Journal of the American College of Cardiology(2024)10.1016/j.jacc.2024.07.043

N/A

0DataRank · unranked

17 citations

Mark V. Sherrid, Paul M.L. Janssen, Giovanni Ferrari, Kohei Hasegawa, Estíbaliz Castillero +7 more

Safety and Efficacy of Aficamten in Patients With Nonobstructive Hypertrophic Cardiomyopathy: A 96-Week Analysis From FOREST-HCM

Journal of Cardiac Failure(2025)10.1016/j.cardfail.2025.09.016

N/A

0DataRank · unranked

1 citations

Mark V. Sherrid, Lubna Choudhury, Pablo García‐Pavía, Christopher M. Kramer, Roberto Barriales‐Villa +18 more

Incidence and Outcomes of Atrial Fibrillation and Systolic Dysfunction in Patients Receiving Mavacamten for Obstructive Hypertrophic Cardiomyopathy: A Multicenter Study

medRxiv(2025)10.1101/2025.09.15.25335783

N/A

0DataRank · unranked

0 citations

Jack Wiedrick, Daniele Massera, Elizabeth Adlestein, Sumar Frejat, Matteo Castrichini +47 more